160 related articles for article (PubMed ID: 20336586)
1. GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance.
Tiwari A
Curr Opin Investig Drugs; 2010 Apr; 11(4):385-93. PubMed ID: 20336586
[TBL] [Abstract][Full Text] [Related]
2. Brain insulin signalling in the regulation of energy balance and peripheral metabolism.
Diamant M
Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes.
Bjenning C; Al-Shamma H; Thomsen W; Leonard J; Behan D
Curr Opin Investig Drugs; 2004 Oct; 5(10):1051-62. PubMed ID: 15535426
[TBL] [Abstract][Full Text] [Related]
4. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid binding receptors and their physiological role in type 2 diabetes.
Swaminath G
Arch Pharm (Weinheim); 2008 Dec; 341(12):753-61. PubMed ID: 19009545
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
7. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
Ruan H; Pownall HJ
Curr Opin Investig Drugs; 2009 Apr; 10(4):346-52. PubMed ID: 19337955
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Kobayashi M; Ikegami H; Fujisawa T; Nojima K; Kawabata Y; Noso S; Babaya N; Itoi-Babaya M; Yamaji K; Hiromine Y; Shibata M; Ogihara T
Diabetes; 2007 Jan; 56(1):239-47. PubMed ID: 17192488
[TBL] [Abstract][Full Text] [Related]
9. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus.
Blaak EE
Proc Nutr Soc; 2004 May; 63(2):323-30. PubMed ID: 15294050
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
Haluzik M
Curr Opin Investig Drugs; 2005 Oct; 6(10):988-93. PubMed ID: 16259219
[TBL] [Abstract][Full Text] [Related]
11. Diabetes, lipids, and adipocyte secretagogues.
Faraj M; Lu HL; Cianflone K
Biochem Cell Biol; 2004 Feb; 82(1):170-90. PubMed ID: 15052336
[TBL] [Abstract][Full Text] [Related]
12. [Resistine--a new hormone secreted by adipose tissue (adipose tissue in insulin resistance)].
Kochan Z; Karbowska J
Przegl Lek; 2003; 60(1):40-2. PubMed ID: 12884646
[TBL] [Abstract][Full Text] [Related]
13. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance.
Blaak EE
Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):391-403. PubMed ID: 16150382
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
Qatanani M; Lazar MA
Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
[TBL] [Abstract][Full Text] [Related]
15. [Molecular targets for new drug discovery to treat type 2 diabetes and obesity].
Bastarrachea RA; Montero JC; Saavedra-Gajardo I; Cerda-Flores R; Machado-Domínguez A; Comuzzie AG
Rev Med Chil; 2008 Jan; 136(1):107-17. PubMed ID: 18483661
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
Lebovitz HE
Diabetes Obes Metab; 2006 May; 8(3):237-49. PubMed ID: 16634983
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and obesity.
Greenfield JR; Campbell LV
Clin Dermatol; 2004; 22(4):289-95. PubMed ID: 15475228
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
19. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2006 Mar; 20(117):355-7. PubMed ID: 16780274
[TBL] [Abstract][Full Text] [Related]
20. Androgens, insulin resistance and vascular disease in men.
Kapoor D; Malkin CJ; Channer KS; Jones TH
Clin Endocrinol (Oxf); 2005 Sep; 63(3):239-50. PubMed ID: 16117808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
